| Robert Wycliffe Cheatham Iii, MD | |
|
3100 Channing Way, Idaho Falls, ID 83404-7533 | |
| (208) 535-4591 | |
| Not Available |
| Full Name | Robert Wycliffe Cheatham Iii |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 3100 Channing Way, Idaho Falls, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518995026 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Wycliffe Cheatham Iii, MD 1044 E Quarry Vista Cir, Sandy, UT 84094-4095 Ph: (208) 535-4591 | Robert Wycliffe Cheatham Iii, MD 3100 Channing Way, Idaho Falls, ID 83404-7533 Ph: (208) 535-4591 |
News Archive
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
At the time when autism spectrum disorder can be first reliably diagnosed, toddlers affected by ASD are already displaying emotional vulnerabilities potentially foreshadowing the emergence of co-morbid affective and behavioral conditions highly prevalent in older children, reports a study published in the Journal of the American Academy of Child and Adolescent Psychiatry.
Conventional wisdom has been that respiratory syncytial virus (RSV) - a common virus that causes infection in the lungs - comes and goes in children without any long lasting impact.
Celgene International Sàrl today announced results of a Phase II study of pomalidomide and dexamethasone in multiple myeloma patients who have failed both lenalidomide and bortezomib. Data were presented by Dr. Martha Lacy of the Mayo Clinic during the American Society of Clinical Oncology annual meeting.
Despite the millions of dollars that have been invested into research to improve methods of treatments for various types of cancer, oncological diseases continue to have a high mortality rate, remaining one of the main causes of death globally. Traditional cancer treatment methods, such as chemotherapy, immunotherapy, and radiotherapy are effective in approximately only half of all patients.
› Verified 7 days ago
Shannon Jenkins, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2860 Channing Way, Suite 100, Idaho Falls, ID 83404 Phone: 208-535-4575 Fax: 208-535-4569 | |
Eric Peter Olson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3430 Washington Parkway, Idaho Falls, ID 83404 Phone: 208-523-3060 Fax: 208-523-0028 | |
Dr. Jeffrey John Aughney, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 3430 Washington Pkwy, Idaho Falls, ID 83404 Phone: 208-523-3060 | |
Brad Reid Edwards, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3430 Washington Pkwy, Idaho Falls, ID 83404 Phone: 208-523-3060 Fax: 208-523-0028 | |
Dr. Nephi Andersen Redd, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3320 S 25th E, Idaho Falls, ID 83404 Phone: 208-656-1500 | |
Dr. Joshua Michael Smith, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3910 Washington Pkwy, Idaho Falls, ID 83404 Phone: 208-523-1122 Fax: 208-523-2582 | |
Dr. Steven Blake Colson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2330 Desoto St, Idaho Falls, ID 83404 Phone: 208-528-1039 Fax: 208-528-1939 |